Teladoc Health accounting chief sells 655 shares for taxes

Q: How many TDOC restricted stock units converted into common shares?

2,083 restricted stock units converted one-for-one into 2,083 common shares on October 1, 2026. Catapano's reported remaining balance after the conversion was 8,335 restricted stock units.

Q: What was the vesting schedule for Joseph Ronald Catapano's TDOC restricted stock unit grant?

Catapano was granted 25,000 restricted stock units on October 1, 2024. The grant terms provide for one-third to vest on the first anniversary, with the remainder vesting in eight substantially equal quarterly installments.

The chief accounting officer's 655-share sale was designated to cover tax withholding tied to restricted stock unit vesting.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Teladoc Health, Inc. (TDOC) Chief Accounting Officer Joseph Ronald Catapano reported that 2,083 restricted stock units converted one-for-one into common shares on October 1, 2026. He sold 655 common shares on October 2, 2026, at $5.6530 per share to cover tax withholding related to vesting. His reported remaining balance was 8,335 restricted stock units. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 3 txns

Insider Catapano Joseph Ronald

Role Chief Accounting Officer

Sold 655 shs ($4K)

Approx. gross sale proceeds $4K

Type	Security	Shares	Price	Value
Sale	Common Stock ^F2	655	$5.653	$4K
Exercise	Restricted Stock Units ^{F1, F3}	2,083	$0.00	$0.00
Exercise	Common Stock ^F1	2,083	--	--

Holdings After Transaction: Restricted Stock Units — 8,335 contracts (Direct); Common Stock — 14,293 shares (Direct)

Footnotes (3)

F1. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3. On October 1, 2024, the reporting person was granted 25,000 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Key Figures

Restricted stock units converted: 2,083 restricted stock units Common shares acquired upon conversion: 2,083 shares Common shares sold: 655 shares +3 more

6 metrics

Restricted stock units converted 2,083 restricted stock units October 1, 2026

Common shares acquired upon conversion 2,083 shares October 1, 2026

Common shares sold 655 shares October 2, 2026

Sale price $5.6530 per share October 2, 2026

Restricted stock units following conversion 8,335 shares Reported balance after the October 1, 2026 conversion

Restricted stock units granted 25,000 restricted stock units Granted October 1, 2024

Key Terms

restricted stock units, one-for-one basis, tax withholding obligation, substantially equal quarterly installments

4 terms

restricted stock units technical

"Restricted stock units convert to shares of TDOC common stock"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

one-for-one basis technical

"convert to shares of TDOC common stock on a one-for-one basis"

tax withholding obligation financial

"Shares sold to cover the tax withholding obligation"

substantially equal quarterly installments financial

"the remainder vesting in eight substantially equal quarterly installments"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many TDOC shares did the chief accounting officer sell, and at what price?

Joseph Ronald Catapano, Teladoc Health's Chief Accounting Officer, sold 655 common shares on October 2, 2026, at $5.6530 per share to cover tax withholding related to vesting of his restricted stock unit awards. No Rule 10b5-1 plan is reported.

How many TDOC restricted stock units converted into common shares?

2,083 restricted stock units converted one-for-one into 2,083 common shares on October 1, 2026. Catapano's reported remaining balance after the conversion was 8,335 restricted stock units.

What was the vesting schedule for Joseph Ronald Catapano's TDOC restricted stock unit grant?

Catapano was granted 25,000 restricted stock units on October 1, 2024. The grant terms provide for one-third to vest on the first anniversary, with the remainder vesting in eight substantially equal quarterly installments.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/05/2026 - 04:06 PM Accepted by SEC EDGAR 10/05/2026 - 04:05 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Catapano Joseph Ronald

(Last)

(First)

(Middle)

C/O TELADOC HEALTH, INC.,

155 E 44TH ST, SUITE 1700

(Street)

NEW YORK

10017

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Teladoc Health, Inc. [ TDOC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	10/01/2026		M		2,083	A	⁽¹⁾	14,948	D
Common Stock	10/02/2026		S		655⁽²⁾	D	$5.653	14,293	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	10/01/2026		M			2,083	⁽³⁾	⁽³⁾	Common Stock	2,083	$0	8,335	D

Explanation of Responses:

1. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

2. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.

3. On October 1, 2024, the reporting person was granted 25,000 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Remarks:

	/s/ Adam C. Vandervoort, Attorney-in-Fact	10/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR